Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 27, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- October 25, 2006: Transfer of 312,787 Ordinary Shares.
- October 26, 2006: Transfer of 117,551 Ordinary Shares.
These transactions were advised to the Company on October 26 and October 27, 2006, respectively.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold an interest in the shares held by the GSK Trust in the same capacity as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan 1991 during the reporting period.
- Confirm the specific dates of notification to the Company regarding these share transfers.
- Review the full terms of the SmithKline Beecham Employee Share Option Plan 1991 to understand the vesting and exercise conditions associated with these transfers.